All In Biotech

Drug Trial Radar · NCT00866697

Efficacy and Safety of Pazopanib Monotherapy After First Line Chemotherapy in Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

A Phase III Study to Evaluate the Efficacy and Safety of Pazopanib Monotherapy Versus Placebo in Women Who Have Not Progressed After First Line Chemotherapy for Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Last checked: Nov 20, 2026Latest source record: Feb 16, 2021 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 940 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

940

Actual

Start

May 26, 2009

Primary completion

Jul 8, 2012

Study completion Aug 24, 2017

Sponsor

Lead sponsor
Novartis PharmaceuticalsNovartis (NVS)
Sponsor type
Industry
Collaborators
GlaxoSmithKline
First posted
Mar 20, 2009

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
Female only, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This was a study to determine whether therapy with pazopanib was effective and safe in women with epithelial ovarian, fallopian tube, or primary peritoneal cancer whose cancer had not progressed on first line chemotherapy.

Conditions

  • Ovarian Cancer

Interventions

  • PazopanibDrug

    Pazopanib 800 mg tablet daily for 104 weeks (24 months)

  • PlaceboDrug

    Matching placebo 800 mg tablet daily, for 104 weeks (24 months).

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Investigator-assessed Progression-free Survival (PFS)Time frame: From the date of randomization until the date of progression or death due to any cause (median time of follow-up was 17.9 months for pazopanib and 12.3 months for placebo)

Locations

318 sites in 17 countries. Site status is shown where the registry gives one.

  • Novartis Investigative Site

    Anaheim, California

  • Novartis Investigative Site

    Baldwin Park, California

  • Novartis Investigative Site

    Bellflower, California

  • Novartis Investigative Site

    Duarte, California

  • Novartis Investigative Site

    Fontana, California

  • Novartis Investigative Site

    Hayward, California

  • Novartis Investigative Site

    Irvine, California

  • Novartis Investigative Site

    Long Beach, California

  • Novartis Investigative Site

    Los Angeles, California

  • Novartis Investigative Site

    Los Angeles, California

  • Novartis Investigative Site

    Los Angeles, California

  • Novartis Investigative Site

    Oakland, California

  • Novartis Investigative Site

    Ontario, California

  • Novartis Investigative Site

    Orange, California

  • Novartis Investigative Site

    Panorama City, California

  • Novartis Investigative Site

    Riverside, California

  • Novartis Investigative Site

    Roseville, California

  • Novartis Investigative Site

    Sacramento, California

  • Novartis Investigative Site

    Sacramento, California

  • Novartis Investigative Site

    San Diego, California

  • Novartis Investigative Site

    San Diego, California

  • Novartis Investigative Site

    San Francisco, California

  • Novartis Investigative Site

    San Jose, California

  • Novartis Investigative Site

    Santa Clara, California

  • Novartis Investigative Site

    South San Francisco, California

  • Novartis Investigative Site

    Vallejo, California

  • Novartis Investigative Site

    Walnut Creek, California

  • Novartis Investigative Site

    Woodland Hills, California

  • Novartis Investigative Site

    Augusta, Georgia

  • Novartis Investigative Site

    Morristown, New Jersey

  • Novartis Investigative Site

    New York, New York

  • Novartis Investigative Site

    New York, New York

  • Novartis Investigative Site

    The Bronx, New York

  • Novartis Investigative Site

    Houston, Texas

  • Novartis Investigative Site

    Annandale, Virginia

  • Novartis Investigative Site

    Melbourne, Australia

  • Novartis Investigative Site

    Camperdown, New South Wales, Australia

  • Novartis Investigative Site

    Liverpool, New South Wales, Australia

  • Novartis Investigative Site

    Randwick, New South Wales, Australia

  • Novartis Investigative Site

    Waratah, New South Wales, Australia

Showing 40 of 318 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.